BioSpace News Archive

ARUP Laboratories, a national reference laboratory and worldwide leader in innovative laboratory research and development, and Techcyte, a leading developer of artificial intelligence (AI)-based image analysis solutions for the diagnostics industry, published a study in the Journal of Clinical Microbiology on their groundbreaking AI-augmented ova and parasite detection tool.

Premier Medical Laboratory Services, a top commercial diagnostic laboratory is now expanding their COVID-19 testing portfolio by adding antibody testing to their offerings.

June 9, 2020 15:00 UTC Phase Ib study to combine UbiVac’s DRibble ® Platform Vaccine, DPV-001 with anti-OX40 (BMS-986178) and Opdivo (nivolumab) to test hypothesis that this combination will augment anticancer immunity in advanced triple negative breast cancer

CURE Pharmaceutical Holding Corp. (OTC: CURR), an innovative drug delivery company that is developing novel ways to deliver active ingredients, announced today that it strengthened its balance sheet with the receipt of $1.4 million in cash from the exercise of warrants to purchase 708,467 shares of CURE’s common stock held by certain stockholders of Chemistry Holdings, Inc. (Chemistry Holdings) at a reduced exercise price of $2.00 per share (

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the Company met with Health Canada in a Pre-Clinical Trial Application (“Pre-CTA”) meeting to evaluate the potential of a clinical study of Bucillamine in the treatment of patients with mild-moderate COVID-19 due to the SARS-CoV-2 inf

4WEB Medical, an orthopedic device company focused on developing innovative implants with an Advanced Structural Design that utilizes its proprietary Truss Implant Technology™, announced today that the company has received 510(k)

New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies, and can guide treatment decisions for patients with Lynch-associated cancers

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that a BAMSTM diagnostic test for the COVID-19 infection, being developed with its partner Adeptrix, has reached prototype stage and can detect the coronavirus spike protein in model samples in the concentration range appropriate for a clinical diagnostic test.

Aurinia Pharmaceuticals Inc. announced that additional safety data from the completed AURORA pivotal trial of voclosporin were shared at the European Renal Association-European Dialysis and Transplant Association 2020 Virtual Congress in an oral presentation given by nephrologist Dawn Caster, M.D., Assistant Professor of Medicine at the University of Louisville School of Medicine.

Stilla Technologies, a leading provider of digital PCR solutions for high-precision genetic analysis, launched the world’s first six-color digital PCR instrument, the six-color Prism.